Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Sell
40
DDOG Quote, Financials, Valuation and Earnings
Last price:
$129.65
Seasonality move
:
-15.22%
Day range:
$123.31 - $133.44
52-week range:
$81.63 - $201.69
Dividend yield:
0%
P/E ratio:
437.63x
P/S ratio:
13.71x
P/B ratio:
13.22x
Volume:
18.8M
Avg. volume:
6.2M
1-year change:
-11.85%
Market cap:
$45.5B
Revenue:
$3.4B
EPS (TTM):
$0.30
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1B | $1.7B | $2.1B | $2.7B | $3.4B | |
| Revenue Growth (YoY) | 70.48% | 62.82% | 27.06% | 26.12% | 27.68% | |
| Cost of Revenues | $234.8M | $347.6M | $410.7M | $516.4M | $687.9M | |
| Gross Profit | $793.9M | $1.3B | $1.7B | $2.2B | $2.7B | |
| Gross Profit Margin | 77.17% | 79.25% | 80.7% | 80.76% | 79.93% | |
| R&D Expenses | $419.8M | $752.4M | $962.4M | $1.2B | $1.5B | |
| Selling, General & Admin | $393.9M | $634.7M | $789.5M | $961.8M | -- | |
| Other Inc / (Exp) | $374K | $2.2M | -$3.5M | $1.4M | -- | |
| Operating Expenses | $813.1M | $1.4B | $1.8B | $2.1B | $2.8B | |
| Operating Income | -$19.2M | -$58.7M | -$33.5M | $54.3M | -$44.4M | |
| Net Interest Expenses | $21.1M | $16.5M | $6.3M | $7.1M | $11.1M | |
| EBT. Incl. Unusual Items | -$18.4M | -$38.1M | $60.2M | $203.9M | $127M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $2.3M | $12.1M | $11.7M | $20.2M | $19.3M | |
| Net Income to Company | -$20.7M | -$50.2M | $48.6M | $183.7M | $107.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$20.7M | -$50.2M | $48.6M | $183.7M | $107.7M | |
| Basic EPS (Cont. Ops) | -$0.07 | -$0.16 | $0.15 | $0.55 | $0.31 | |
| Diluted EPS (Cont. Ops) | -$0.07 | -$0.16 | $0.14 | $0.51 | $0.30 | |
| Weighted Average Basic Share | $309M | $315.4M | $324M | $336.2M | $347.3M | |
| Weighted Average Diluted Share | $309M | $315.4M | $350.3M | $358.6M | $363.5M | |
| EBITDA | $3.8M | $3.9M | $50.2M | $161.3M | $78.2M | |
| EBIT | -$19.2M | -$58.7M | -$33.5M | $54.3M | -$44.4M | |
| Revenue (Reported) | $1B | $1.7B | $2.1B | $2.7B | $3.4B | |
| Operating Income (Reported) | -$19.2M | -$58.7M | -$33.5M | $54.3M | -$44.4M | |
| Operating Income (Adjusted) | -$19.2M | -$58.7M | -$33.5M | $54.3M | -$44.4M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $326.2M | $469.4M | $589.6M | $737.7M | $953.2M | |
| Revenue Growth (YoY) | 83.74% | 43.9% | 25.62% | 25.11% | 29.21% | |
| Cost of Revenues | $67.4M | $97M | $105M | $144.4M | $187.2M | |
| Gross Profit | $258.8M | $372.4M | $484.6M | $593.3M | $766M | |
| Gross Profit Margin | 79.35% | 79.34% | 82.19% | 80.43% | 80.36% | |
| R&D Expenses | $133M | $218.7M | $253.3M | $316.3M | $417.9M | |
| Selling, General & Admin | $117.5M | $188.6M | $203.8M | $267.8M | -- | |
| Other Inc / (Exp) | $239K | -$1.8M | -$2M | $4.5M | -- | |
| Operating Expenses | $250.4M | $407.1M | $456.9M | $584M | $756.7M | |
| Operating Income | $8.5M | -$34.6M | $27.7M | $9.4M | $9.4M | |
| Net Interest Expenses | $5.6M | $3M | $1.3M | $2.6M | $2.6M | |
| EBT. Incl. Unusual Items | $8.5M | -$25.9M | $57.3M | $53.8M | $53.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.4M | $3.2M | $3.3M | $8.2M | $6.9M | |
| Net Income to Company | $7.2M | -$29M | $54M | $45.6M | $46.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $7.2M | -$29M | $54M | $45.6M | $46.6M | |
| Basic EPS (Cont. Ops) | $0.02 | -$0.09 | $0.16 | $0.13 | $0.13 | |
| Diluted EPS (Cont. Ops) | $0.02 | -$0.09 | $0.15 | $0.13 | $0.13 | |
| Weighted Average Basic Share | $311.8M | $317.3M | $328.9M | $340.3M | $350.9M | |
| Weighted Average Diluted Share | $345.9M | $317.3M | $352.9M | $360.9M | $365.5M | |
| EBITDA | $15.3M | -$16.8M | $50.8M | $39.4M | $44.7M | |
| EBIT | $8.5M | -$34.6M | $27.7M | $9.4M | $9.4M | |
| Revenue (Reported) | $326.2M | $469.4M | $589.6M | $737.7M | $953.2M | |
| Operating Income (Reported) | $8.5M | -$34.6M | $27.7M | $9.4M | $9.4M | |
| Operating Income (Adjusted) | $8.5M | -$34.6M | $27.7M | $9.4M | $9.4M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1B | $1.7B | $2.1B | $2.7B | $3.4B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $234.5M | $347.6M | $410.7M | $516.4M | $687.9M | |
| Gross Profit | $794.3M | $1.3B | $1.7B | $2.2B | $2.7B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $419.8M | $752.4M | $962.4M | $1.2B | $1.5B | |
| Selling, General & Admin | $393.9M | $634.7M | $789.5M | $961.8M | $897.1M | |
| Other Inc / (Exp) | $374K | $2.2M | -$3.5M | $1.4M | -- | |
| Operating Expenses | $813.5M | $1.4B | $1.8B | $2.1B | $2.8B | |
| Operating Income | -$19.2M | -$58.7M | -$33.5M | $54.3M | -$44.4M | |
| Net Interest Expenses | $21.1M | $16.5M | $6.3M | $7.1M | $11.1M | |
| EBT. Incl. Unusual Items | -$18.4M | -$38.1M | $60.2M | $203.9M | $127M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $2.3M | $12.1M | $11.7M | $20.2M | $19.3M | |
| Net Income to Company | -$20.7M | -$50.2M | $48.6M | $183.7M | $107.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$20.7M | -$50.2M | $48.6M | $183.7M | $107.7M | |
| Basic EPS (Cont. Ops) | -$0.07 | -$0.16 | $0.15 | $0.55 | $0.31 | |
| Diluted EPS (Cont. Ops) | -$0.07 | -$0.16 | $0.13 | $0.51 | $0.30 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $3.8M | -$16M | $22M | $135.2M | $78.1M | |
| EBIT | -$19.2M | -$58.7M | -$33.5M | $54.3M | -$44.4M | |
| Revenue (Reported) | $1B | $1.7B | $2.1B | $2.7B | $3.4B | |
| Operating Income (Reported) | -$19.2M | -$58.7M | -$33.5M | $54.3M | -$44.4M | |
| Operating Income (Adjusted) | -$19.2M | -$58.7M | -$33.5M | $54.3M | -$44.4M | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.7B | $2.1B | $2.7B | $3.4B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $347.6M | $410.7M | $516.4M | $687.9M | -- | |
| Gross Profit | $1.3B | $1.7B | $2.2B | $2.7B | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $752.4M | $962.4M | $1.2B | $1.5B | -- | |
| Selling, General & Admin | $634.7M | $789.5M | $961.8M | $897.1M | -- | |
| Other Inc / (Exp) | $2.2M | -$3.5M | $1.4M | -$11M | -- | |
| Operating Expenses | $1.4B | $1.8B | $2.1B | $2.8B | -- | |
| Operating Income | -$58.7M | -$33.5M | $54.3M | -$44.4M | -- | |
| Net Interest Expenses | $16.5M | $6.3M | $7.1M | $11.1M | -- | |
| EBT. Incl. Unusual Items | -$38.1M | $60.2M | $203.9M | $127M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $12.1M | $11.7M | $20.2M | $19.3M | -- | |
| Net Income to Company | -$50.2M | $48.6M | $183.7M | $107.7M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$50.2M | $48.6M | $183.7M | $107.7M | -- | |
| Basic EPS (Cont. Ops) | -$0.16 | $0.15 | $0.55 | $0.31 | -- | |
| Diluted EPS (Cont. Ops) | -$0.16 | $0.13 | $0.51 | $0.30 | -- | |
| Weighted Average Basic Share | $1.3B | $1.3B | $1.3B | $1.4B | -- | |
| Weighted Average Diluted Share | $1.3B | $1.3B | $1.4B | $1.4B | -- | |
| EBITDA | -$16M | $22M | $135.2M | $78.1M | -- | |
| EBIT | -$58.7M | -$33.5M | $54.3M | -$44.4M | -- | |
| Revenue (Reported) | $1.7B | $2.1B | $2.7B | $3.4B | -- | |
| Operating Income (Reported) | -$58.7M | -$33.5M | $54.3M | -$44.4M | -- | |
| Operating Income (Adjusted) | -$58.7M | -$33.5M | $54.3M | -$44.4M | -- | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.6B | $1.9B | $2.6B | $4.2B | $4.5B | |
| Short Term Investments | $1.3B | $1.5B | $2.3B | $2.9B | -- | |
| Accounts Receivable, Net | $268.8M | $399.6M | $509.3M | $598.9M | $741.3M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $13.7M | -- | -- | -- | -- | |
| Other Current Assets | $24.4M | $27.3M | $41M | $67M | -- | |
| Total Current Assets | $1.8B | $2.3B | $3.1B | $4.9B | $5.3B | |
| Property Plant And Equipment | $136.5M | $213M | $298.4M | $399.5M | $552.8M | |
| Long-Term Investments | $3.5M | $3.3M | -- | -- | -- | |
| Goodwill | $292.2M | $348.3M | $352.7M | $360.4M | -- | |
| Other Intangibles | $15.7M | $16.4M | $9.6M | $3.7M | -- | |
| Other Long-Term Assets | $23.4M | $27.7M | $23.5M | $24.1M | -- | |
| Total Assets | $2.4B | $3B | $3.9B | $5.8B | $6.6B | |
| Accounts Payable | $25.3M | $23.5M | $87.7M | $107.7M | $148.8M | |
| Accrued Expenses | $50.9M | $98.6M | $35.3M | $26.8M | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | $634M | -- | |
| Current Portion Of Capital Lease Obligations | $20.2M | $22.1M | $22M | $32M | -- | |
| Other Current Liabilities | $33K | -- | -- | -- | -- | |
| Total Current Liabilities | $528.7M | $759.7M | $1B | $1.9B | $1.6B | |
| Long-Term Debt | $787.6M | $815.4M | $880.4M | $1.2B | $1.2B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.3B | $1.6B | $1.9B | $3.1B | $2.9B | |
| Common Stock | $3K | $3K | $3K | $3K | $3K | |
| Other Common Equity Adj | -$3.8M | -$12.4M | -$2.2M | -$4.7M | -- | |
| Common Equity | $1B | $1.4B | $2B | $2.7B | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $1B | $1.4B | $2B | $2.7B | $3.7B | |
| Total Liabilities and Equity | $2.4B | $3B | $3.9B | $5.8B | $6.6B | |
| Cash and Short Terms | $1.6B | $1.9B | $2.6B | $4.2B | $4.5B | |
| Total Debt | $787.6M | $815.4M | $880.4M | $1.8B | $1.2B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.6B | $1.9B | $2.6B | $4.2B | $4.5B | |
| Short Term Investments | $1.3B | $1.5B | $2.3B | $2.9B | -- | |
| Accounts Receivable, Net | $268.8M | $399.6M | $509.3M | $598.9M | $741.3M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $13.7M | -- | -- | -- | -- | |
| Other Current Assets | $24.4M | $27.3M | $41M | $67M | -- | |
| Total Current Assets | $1.8B | $2.3B | $3.1B | $4.9B | $5.3B | |
| Property Plant And Equipment | $136.5M | $213M | $298.4M | $399.5M | $552.8M | |
| Long-Term Investments | $3.5M | $3.3M | -- | -- | -- | |
| Goodwill | $292.2M | $348.3M | $352.7M | $360.4M | -- | |
| Other Intangibles | $15.7M | $16.4M | $9.6M | $3.7M | -- | |
| Other Long-Term Assets | $23.4M | $27.7M | $23.5M | $24.1M | -- | |
| Total Assets | $2.4B | $3B | $3.9B | $5.8B | $6.6B | |
| Accounts Payable | $25.3M | $23.5M | $87.7M | $107.7M | $148.8M | |
| Accrued Expenses | $50.9M | $98.6M | $35.3M | $26.8M | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | $634M | -- | |
| Current Portion Of Capital Lease Obligations | $20.2M | $22.1M | $22M | $32M | -- | |
| Other Current Liabilities | $33K | -- | -- | -- | -- | |
| Total Current Liabilities | $528.7M | $759.7M | $1B | $1.9B | $1.6B | |
| Long-Term Debt | $787.6M | $815.4M | $880.4M | $1.2B | $1.2B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.3B | $1.6B | $1.9B | $3.1B | $2.9B | |
| Common Stock | $3K | $3K | $3K | $3K | $3K | |
| Other Common Equity Adj | -$3.8M | -$12.4M | -$2.2M | -$4.7M | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $1B | $1.4B | $2B | $2.7B | $3.7B | |
| Total Liabilities and Equity | $2.4B | $3B | $3.9B | $5.8B | $6.6B | |
| Cash and Short Terms | $1.6B | $1.9B | $2.6B | $4.2B | $4.5B | |
| Total Debt | $787.6M | $815.4M | $880.4M | $1.8B | $1.2B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$20.7M | -$50.2M | $48.6M | $183.7M | $107.7M | |
| Depreciation & Amoritzation | $22.9M | $62.6M | $83.7M | $107M | $122.5M | |
| Stock-Based Compensation | $163.7M | $363.2M | $482.3M | $570.3M | $750.7M | |
| Change in Accounts Receivable | -$107.1M | -$135.7M | -$121.7M | -$104.5M | -$157.4M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $286.5M | $418.4M | $660M | $870.6M | $1.1B | |
| Capital Expenditures | $36M | $64.9M | $62.4M | $95.5M | $135.4M | |
| Cash Acquisitions | $226.5M | $45.9M | $12.5M | $7.1M | $118M | |
| Cash From Investing | -$273.7M | -$384.7M | -$731.4M | -$736.8M | -$1.3B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | $1B | -- | |
| Long-Term Debt Repaid | -- | -$3K | -- | -$297.7M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$245K | -- | -- | -- | -- | |
| Cash From Financing | $34.9M | $36M | $58.3M | $787.1M | -$572.5M | |
| Beginning Cash (CF) | $274.5M | $339M | $330.3M | $1.2B | $401.3M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $45.8M | $67.8M | -$11.9M | $916.6M | -$845.7M | |
| Ending Cash (CF) | $318.2M | $404.9M | $319.6M | $2.2B | -$433.2M | |
| Levered Free Cash Flow | $250.5M | $353.5M | $597.5M | $775.1M | $914.7M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $7.2M | -$29M | $54M | $45.6M | $46.6M | |
| Depreciation & Amoritzation | $6.9M | $37.8M | $51.2M | $67.8M | $35.3M | |
| Stock-Based Compensation | $56.4M | $112.5M | $128.1M | $158.5M | $205.4M | |
| Change in Accounts Receivable | -$45.2M | -$52M | -$111.5M | -$116.3M | -$196.3M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $115.8M | $114.4M | $220.2M | $265.2M | $327.1M | |
| Capital Expenditures | $9.1M | $18.1M | $18.9M | $24.3M | $36M | |
| Cash Acquisitions | $26.3M | $5.6M | $6.1M | $6.5M | $700K | |
| Cash From Investing | -$146M | -$89.1M | -$174M | -$109.4M | -$497.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -$297.6M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $14.7M | $14.2M | $20.9M | $759.4M | $30M | |
| Beginning Cash (CF) | $274.5M | $339M | $330.3M | $1.2B | $401.3M | |
| Foreign Exchange Rate Adjustment | -$573K | $4.9M | $2M | -$5.7M | $1.4M | |
| Additions / Reductions | -$16.1M | $44.5M | $69M | $909.6M | -$139.3M | |
| Ending Cash (CF) | $257.8M | $388.4M | $401.3M | $2.2B | $263.4M | |
| Levered Free Cash Flow | $106.7M | $96.4M | $201.3M | $241M | $291M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$20.7M | -$50.2M | $48.6M | $183.7M | $107.7M | |
| Depreciation & Amoritzation | $22.9M | $62.6M | $83.7M | $107M | $122.5M | |
| Stock-Based Compensation | $163.7M | $363.2M | $482.3M | $570.3M | $750.7M | |
| Change in Accounts Receivable | -$107.1M | -$135.7M | -$121.7M | -$104.5M | -$157.4M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $286.5M | $418.4M | $660M | $870.6M | $1.1B | |
| Capital Expenditures | $36M | $64.9M | $62.4M | $95.5M | $135.4M | |
| Cash Acquisitions | $226.5M | $45.9M | $12.5M | $7.1M | $118M | |
| Cash From Investing | -$273.7M | -$384.7M | -$731.4M | -$736.8M | -$1.3B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -$3K | -- | -$297.7M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$245K | -- | -- | -- | -- | |
| Cash From Financing | $34.9M | $36M | $58.3M | $787.1M | -$572.5M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $45.8M | $67.8M | -$11.9M | $916.6M | -$845.7M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $250.5M | $353.5M | $597.5M | $775.1M | $914.7M | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$50.2M | $48.6M | $183.7M | $107.7M | -- | |
| Depreciation & Amoritzation | $62.6M | $83.7M | $107M | $122.5M | -- | |
| Stock-Based Compensation | $363.2M | $482.3M | $570.3M | $750.7M | -- | |
| Change in Accounts Receivable | -$135.7M | -$121.7M | -$104.5M | -$157.4M | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $418.4M | $660M | $870.6M | $1.1B | -- | |
| Capital Expenditures | $64.9M | $62.4M | $95.5M | $135.4M | -- | |
| Cash Acquisitions | $45.9M | $12.5M | $7.1M | $118M | -- | |
| Cash From Investing | -$384.7M | -$731.4M | -$736.8M | -$1.3B | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$3K | -- | -$297.7M | -$635.7M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $36M | $58.3M | $787.1M | -$572.5M | -- | |
| Beginning Cash (CF) | $1.1B | $1.1B | $2.3B | $2.5B | -- | |
| Foreign Exchange Rate Adjustment | -$1.9M | $1.2M | -$4.2M | $11.2M | -- | |
| Additions / Reductions | $67.8M | -$11.9M | $916.6M | -$845.7M | -- | |
| Ending Cash (CF) | $1.2B | $1.1B | $3.2B | $1.7B | -- | |
| Levered Free Cash Flow | $353.5M | $597.5M | $775.1M | $914.7M | -- | |
Related Companies
Get DDOG Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
DDOG
Sector
P/E ratio
437.63x
24.38x
PEG ratio
6.81x
0.00x
P/B ratio
13.22x
2.17x
Price / LTM sales
13.71x
1.40x
Growth Metrics
DDOG
Sector
Revenue growth
29.21%
6.35%
Earnings growth
0.87%
9.35%
Revenue (5-year growth)
41.53%
4.89%
Earnings forecast
$0.55
$0.14
Profitability
DDOG
Sector
Profitability FY 2025
$2.7B
$28.3M
Return on invested capital
2.29%
-0.74%
Return on assets
1.78%
-1.59%
Return on equity
3.37%
0.14%
Earnings Date
Last Earnings Date
Feb
10
Next Earnings Date
Feb
11
Estimated Next Earnings Date
May
13
Balance Sheet
DDOG
Sector
Total cash
$4.5B
$38.6M
Short term investments
$2.9B
$16.1M
Total assets
$6.6B
$149.3M
Long term debt
$1.2B
$3.9M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
58
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Sell
48
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 29x
Alerts
Buy
73
NKTR alert for Feb 11
Nektar Therapeutics [NKTR] is up 12.71% over the past day.
Buy
53
ICHR alert for Feb 11
Ichor Holdings Ltd. [ICHR] is up 1.26% over the past day.
Sell
26
MEDP alert for Feb 11
Medpace Holdings, Inc. [MEDP] is down 3.67% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
